Corrigendum to “Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial” [Respir. Med. 230 (2024) 107693]
Jussi Karjalainen , Ville Vartiainen , Antti Tikkakoski , L. Pekka Malmberg , Liisa Vuotari , Satu Lähelmä , Ulla Sairanen , Mikko Vahteristo , Lauri Lehtimaki
{"title":"Corrigendum to “Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial” [Respir. Med. 230 (2024) 107693]","authors":"Jussi Karjalainen , Ville Vartiainen , Antti Tikkakoski , L. Pekka Malmberg , Liisa Vuotari , Satu Lähelmä , Ulla Sairanen , Mikko Vahteristo , Lauri Lehtimaki","doi":"10.1016/j.rmed.2024.107715","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0954611124001902/pdfft?md5=333b5126150f6697f53eca37caa41181&pid=1-s2.0-S0954611124001902-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0954611124001902","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
期刊介绍:
Respiratory Medicine is an internationally-renowned journal devoted to the rapid publication of clinically-relevant respiratory medicine research. It combines cutting-edge original research with state-of-the-art reviews dealing with all aspects of respiratory diseases and therapeutic interventions. Topics include adult and paediatric medicine, epidemiology, immunology and cell biology, physiology, occupational disorders, and the role of allergens and pollutants.
Respiratory Medicine is increasingly the journal of choice for publication of phased trial work, commenting on effectiveness, dosage and methods of action.